Correlation Between CureVac NV and Tandem Diabetes
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Tandem Diabetes Care, you can compare the effects of market volatilities on CureVac NV and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Tandem Diabetes.
Diversification Opportunities for CureVac NV and Tandem Diabetes
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CureVac and Tandem is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of CureVac NV i.e., CureVac NV and Tandem Diabetes go up and down completely randomly.
Pair Corralation between CureVac NV and Tandem Diabetes
Given the investment horizon of 90 days CureVac NV is expected to under-perform the Tandem Diabetes. In addition to that, CureVac NV is 1.12 times more volatile than Tandem Diabetes Care. It trades about -0.02 of its total potential returns per unit of risk. Tandem Diabetes Care is currently generating about 0.01 per unit of volatility. If you would invest 4,128 in Tandem Diabetes Care on September 3, 2024 and sell it today you would lose (1,065) from holding Tandem Diabetes Care or give up 25.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
CureVac NV vs. Tandem Diabetes Care
Performance |
| Timeline |
| CureVac NV |
| Tandem Diabetes Care |
CureVac NV and Tandem Diabetes Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CureVac NV and Tandem Diabetes
The main advantage of trading using opposite CureVac NV and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.| CureVac NV vs. Tandem Diabetes Care | CureVac NV vs. Teleflex Incorporated | CureVac NV vs. Virgin Group Acquisition | CureVac NV vs. Cumberland Pharmaceuticals |
| Tandem Diabetes vs. DexCom Inc | Tandem Diabetes vs. Inspire Medical Systems | Tandem Diabetes vs. Penumbra | Tandem Diabetes vs. Insulet |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |